Loading...

Isodiol International Inc.

ISOLFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Isodiol International Inc. (ISOLF) Company Profile & Overview

Explore Isodiol International Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Isodiol International Inc. (ISOLF) Company Profile & Overview

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMarcos Agramont

Contact Information

604 409 4409
200 Granville Street, Vancouver, BC, V6C 1S4

Company Facts

IPO DateNov 20, 2014
CountryCA
Actively Trading

Frequently Asked Questions

;